leaves
Senior Member
- Messages
- 1,193
extreme risk aversion maybe?
What amazed me about today was the fact that we were all kept so busy! I've never seen a CFSAC meeting like today's. They trotted out all of these nice speakers, many who had nothing to offer us at all, and just kept talking about all these "other" things completely redirecting attention from the issue of XMRV. (head shake)
So the question that I have to ask, is this an attempt to bury the research? I mean what is the point of ignoring the XMRV question so completely? If we just pretend the elephant isn't in the room will that make it disappear? This is "our" advisory committee, they have our interest at heart why all the pretending??? In the desperate attempts to buy time today would, get either get top ranking or bottom ranking I'm not sure which, as just plain crazy.
Is anyone mentioning WPI in the testimonies? My computer had problems even when the video was on. I think we have to back up WPI especially since they weren't invited speakers and they are working for us. Carol's testimony second to last was both militant and heart breaking and K Baker who got cut off was great. What did he say about contamination? I think all the attendees can't help but be affected by these testimonies and keep fighting for us or have their eyes opened. But we have to talk about XMRV since they are in a bubble.
What we are witnessing are delaying tactics. There is no way in hell they can bury prostate cancer, which causes 10,000 deaths per year in the UK alone. Take the 27% preliminary finding of Ila Singh about XMRV in prostate cancer, and you have 2,700 deaths possibly caused by XMRV each year. And, we haven't even begun to look at all viral variants....But I have also had an epiphany that if they do try to bury the XMRV/ME link, theres nothing we can do about it. And we have to be prepared for this possibility. We have absolutely now power to change the outcome. All we have to hope is that the WPI and Co can prove there are many people infected with the virus...
Whoa! (Woe?)So what you're suggesting is that government officials are ignoring XMRV/HMRV in ME/CFS or have decided that it's not causal for ME/CFS. What may be going on behind the scene's is that ME/CFS will get busted up in to smaller groups of cancer patients, and other already defined illnesses that will be determined to be caused by XMRV/HMRV. Meaning there is no ME/CFS only XMRV/HMRV illness of which we will each get sub-grouped into and treated for. So all this is just a delay tactic until they can figure out how to spin that out and make it stick. hmmm, it actually sounds quite reasonable. If I'm reading you right. If not I apologized my brain just plain hurts today.
The good thing about such a scenario is it would make treatment and diagnosis much easier for doctors and patients. The bad thing would be that you would be talking about a 7 to 10 year spread before things could be put into place for treatment. (sigh)
What we are witnessing are delaying tactics. There is no way in hell they can bury prostate cancer, which causes 10,000 deaths per year in the UK alone. Take the 27% preliminary finding of Ila Singh about XMRV in prostate cancer, and you have 2,700 deaths possibly caused by XMRV each year. And, we haven't even begun to look at all viral variants.
From prostate cancer, we go to precursor conditions, like chronic non-bacterial prostatitis. This has no known etiology. In females the corresponding condition is called interstitial cystitis, which doesn't mean anyone understands that etiology either. Urologists in research are now grouping all these conditions under a single label. Guess what? These conditions show up at elevated rates in ME/CFS. The connection between infected prostates and neurological disease in the associated nerves is fairly direct.
The current mess in diagnosis is the result of dumping many different patients in one wastebasket. The naysayers aren't going to challenge diagnostic criteria of others while there is a biomarker in 80% of the group, because they have absolutely no marker to identify their preferred cohorts, only opinions. That is why they are challenging the biomarker itself. They are concentrating on a single test, because they have no answer to others. Their position is going to get worse as more biomarkers with different tests become available. Here is an example which may (or may not) be connected, a possible biomarker for precancerous changes in the prostate. (This also gives a gene change to search for.) There is also a urine test for XMRV (HMRV) on the way. Because urine passes through an infected organ, this may be more sensitive than simple blood tests, and considerably cheaper.
Serological tests for HMRV are now available, though not approved. These bypass many objections to the PCR tests. You don't get a serological response to laboratory contamination.
MRS scans showing damage to dorsal root ganglia have now been followed by confirmation at autopsy. No neurologist is likely to say finding T-8 lymphocytes there is normal. Meanwhile, the bodies are piling up in Singh's study of all possible XMRV-affected organs in deaths from all causes.
I haven't even touched on the statistical link with lymphomas/leukemia, which is worrying enough when confined to PWC, and now shows up in those around them.
Look at the rise in incidence of prostate cancer and unusual lymphomas after 1985. These are major public health concerns. The disarray in the naysayers camp is over ways to disengage ME/CFS from connection with illnesses they dare not downplay. This is going to become steadily more difficult.
Delay is possible, but only for a limited time.
Would you be having a rough day or week? (Or perhaps your own experience with cliques of UK insiders is distorting your view of a world which is considerably more diverse.)Sorry anciendaze,
You misunderstand. Of course prostate cancer and XMRV cannot be buried, but the powers that be can legitimately dismiss any XMRV link with an ambiguous disorder that has been redefined umpteen times in the last several decades, and seems to have a different definition wherever you look...
I'm trying to catch up. I just watched Dr. Joan Grobstein (who I know) - patient testimony #2 at:this is the line up for public comments today. 5 min each comment.
Wednesday, October 13, 2010
* Friedberg, Fred
* Grobstein, Joan
* Johnson, Cort
* Hennessey, Thomas
* Shannon, Meghan
* McGrory Richardson, Nancy
* Adonailo, David
* Lopez-Majano, Denise
* Miller, Robert
* Dessin, Mike
* Schweitzer, Mary
* Silverman, Marly
* Geraci, Carol
* Baker, Keith
* Fero, Pat
* Magowitz, Susan